Transgene Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Transgene

Transgene S.A. | Mutual Funds

Mutual Funds that own Transgene S.A.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Royance Sélection Internationale

835,754

1.34%

13.53%

05/31/2018

LBPAM Actions Santé

183,076

0.28%

0.44%

06/29/2018

75,000

0.12%

75,000

0.91%

11/30/2017

OAK Tree Small & Mid Caps Europe Fund

44,400

0.07%

6.19%

12/31/2017

LAM - Euro - Small Caps - UNIVERSAL

24,000

0.04%

0.37%

06/29/2018

RAM (Lux) Systematic Funds - European Equities

17,311

0.03%

17,311

0.01%

06/30/2017

15,903

0.03%

4,930

0.52%

06/30/2017

12,584

0.02%

-373

0.26%

06/29/2018

Martin Maurel Vie

8,280

0.01%

-7,185

0.01%

12/31/2015

Arcalis

4,666

0.01%

-3,853

12/31/2015

About Transgene

View Profile

Address	400 Boulevard Gonthier dAndernach Strasbourg Alsace 67405 France
Employees	-
Website	http://www.transgene.fr
Updated	07/08/2019
Transgene SA is a biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4010, Pexa-Vec, TG4001, TG6002, TG1050, and TG4040. The company was founded in December 1979 and is headquartered in Strasbourg, France.